Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Immunol Res. 2014 Aug;59(0):166–176. doi: 10.1007/s12026-014-8525-0

Table II.

Correlates of protection following whole sporozoite vaccination approaches.

Whole sporozoite vaccination approach Vaccination-induced responses


Radiation-attenuated sporozoites (RAS) CD8 T cells CD4 T cells Antibodies
Mouse Required for protection [2933]. Generally not required for protection, dependent on mouse strain [29]. Anti-sporozoite antibodies did not correlate with protection [30].
Non-human primate IFNγ+, TNFα+ CD8 T cells detected in liver following ex vivo sporozoite stimulation [33]. IFNγ+, TNFα+, or IL-2+ CD4 T cells detected in liver following ex vivo sporozoite stimulation [33]. N.D.*
Human Peripheral blood IFNγ+, TNFα+, IL-2+ CD8 T cells detected following ex vivo sporozoite stimulation [16]. Peripheral blood IFNγ+, TNFα+, IL-2+ CD4 T cells detected following ex vivo sporozoite stimulation [16,33]. Anti-CSP antibodies induced [16,33].
Genetically-attenuated parasites (GAP)
Mouse Required for protection [10, 3639]. Not required for protection [30,36,38]. N.D.*
Human Peripheral blood IFNγ+ CD8 T cells detected following ex vivo sporozoite stimulation [18]. Peripheral blood IFNγ+, TNFα+, IL-2+ CD4 T cells detected following ex vivo sporozoite stimulation [18]. Antibodies capable of inhibiting in vitro hepatocyte invasion detected [18].
Infection-treatment vaccination Mouse Requirement for protection differs by rodent/ parasite immunization model. Not required for protection in C57Bl/6-P. yoelii 17XNL [23]. Partially reduces liver parasite burden in BALB/c-P. yoelii YM265 model [9]. Not required for protection – can delete population just prior to challenge [23]. Partially reduces liver parasite burden in BALB/c-P. yoelii YM265 model [9]. Anti-blood-stage parasite antibodies correlated with protection in C57Bl/6-P. yoelii 17XNL model [23].
Human Detectable peripheral blood IFNγ+, IL-2+ CD8 T cell response following ex vivo blood-stage parasite stimulation [21]. Peripheral blood IFNγ+, IL-2+ CD4 T cell response following ex vivo blood-stage parasite stimulation [21]. Anti-CSP antibodies induced [20,21].
*

Indicates not discussed in review.